| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.23 | 0.0003 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |